MesotheliomaCenter's

Mesothelioma-Line

Curated Journal Articles on Mesothelioma

Category Archives: Treatment

Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing

PloS one 2018 January [Link] Patch AM et. al. Abstract Technological innovation and increased affordability have contributed to the widespread adoption of genome sequencing technologies in biomedical research. In particular large cancer research consortia have embraced next generation sequencing, and have used the technology to define the somatic mutation landscape of multiple cancer types. These […]

Comments Off on Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing

Malign pleural mesothelioma – so far an undefeated tumor

Vnitrni lekarstvi 2018 [Link] Kolek V. Abstract Malign pleural mesothelioma is the most frequent primary tumor of the pleura of high aggressiveness. Its most frequent cause is contact with asbestos and, although working with asbestos is already prohibited in developed countries, its incidence is on the increase so far. Diagnostics primarily considers anamnesis, clinical symptoms […]

Comments Off on Malign pleural mesothelioma – so far an undefeated tumor

Focal Adhesion Kinase a Potential Therapeutic Target for Pancreatic Cancer and Malignant Pleural Mesothelioma

Cancer Biology & Therapy 2018 January 5 [Epub ahead of print] [Link] Kanteti R, et. al. Abstract The non-receptor cytoplasmic tyrosine kinase, Focal Adhesion Kinase (FAK) is known to play a key role in a variety of normal and cancer cellular functions such as survival, proliferation, migration and invasion. It is highly active and overexpressed […]

Comments Off on Focal Adhesion Kinase a Potential Therapeutic Target for Pancreatic Cancer and Malignant Pleural Mesothelioma

Radical multimodality therapy for malignant pleural mesothelioma

The Cochrane Database of Systematic Reviews 2018 January 8 [Epub ahead of print] [Link] Abdel-Rahman O, Elsayed Z, Mohamed H, Eltobgy M Abstract BACKGROUND: Malignant pleural mesothelioma is an almost always fatal tumour, for which palliative platinum-based chemotherapy is currently the standard treatment. Multimodal therapeutic strategies incorporating surgery, radiation therapy or photodynamic therapy and chemotherapy […]

Comments Off on Radical multimodality therapy for malignant pleural mesothelioma

A genetic variant of NLRP1 gene is associated with asbestos body burden in patients with malignant pleural mesothelioma

Journal of Toxicology 2017 December [Epub ahead of print] [Link] Crovella S. et.al. Abstract The presence of asbestos bodies (ABs) in lung parenchyma is considered a histopathologic hallmark of past exposure to asbestos fibers, of which there was a population of longer fibers. The mechanisms underlying AB formation are complex, involving inflammatory responses and iron […]

Comments Off on A genetic variant of NLRP1 gene is associated with asbestos body burden in patients with malignant pleural mesothelioma

Exhaled breath to screen for malignant pleural mesothelioma: a validation study

The European Respiratory Journal 2017 December 21 [Link] Lamote K, Vynck M, Thas O, Van Cleemput J, Nackaerts K, van Meerbeeck JP Abstract Malignant pleural mesothelioma (MPM) is predominantly caused by asbestos exposure and has a poor prognosis. Breath contains volatile organic compounds (VOCs) and can be explored as an early detection tool. Previously, we […]

Comments Off on Exhaled breath to screen for malignant pleural mesothelioma: a validation study

Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth

Frontiers in Immunology 2017 November [Link] Agostinis C et. al. Abstract C1q is the first recognition subcomponent of the complement classical pathway, which acts toward the clearance of pathogens and apoptotic cells. C1q is also known to modulate a range of functions of immune and non-immune cells, and has been shown to be involved in […]

Comments Off on Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth

Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma

European Journal of Cardio-Thoracic Surgery 2017 December [Epub ahead of print] [Link] Nelson DB et. al Abstract OBJECTIVES: Malignant pleural mesothelioma is an aggressive and rare malignancy that frequently recurs despite aggressive therapy. We evaluated the frequency of treatment with surgery, radiation or chemotherapy, changes in therapy and survival over time and factors associated with […]

Comments Off on Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma

Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane

Free Radical Biology and Medicine 2017 December [Epub ahead of print] [Link] Nuvoli B, Camera E, Mastrofrancesco A, Briganti S, Galati R Abstract Pleural mesothelioma is a deadly form of cancer. The prognosis is extremely poor due to the limited treatment modalities. Uptake of asbestos fibres, the leading cause of mesothelioma, lead to the accumulation […]

Comments Off on Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane

National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study

The Annals of Thoracic Surgery 2017 December [Epub ahead of print] [Link] Saddoughi SA, Abdelsattar ZM, Blackmon SH Abstract BACKGROUND: Malignant pleural mesothelioma (MPM) remains an aggressive malignancy that is difficult to cure. However, the treatment paradigm of MPM has evolved, and the national practice patterns are unknown. This study examined the national trends in […]

Comments Off on National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study